Edgewise Therapeutics Inc (EWTX) Stock: What Does the Chart Say Thursday?

The market has been down on Edgewise Therapeutics Inc (EWTX) stock recently. EWTX gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Edgewise Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on EWTX!

See Full EWTX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With EWTX Stock Today?

Edgewise Therapeutics Inc (EWTX) stock is higher by 4.63% while the S&P 500 has fallen -0.23% as of 12:20 PM on Thursday, Nov 30. EWTX has gained $0.29 from the previous closing price of $6.26 on volume of 687,659 shares. Over the past year the S&P 500 has gained 14.72% while EWTX has fallen -27.70%. EWTX lost -$1.41 per share in the over the last 12 months.

More About Edgewise Therapeutics Inc

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. Click Here to get the full Stock Report for Edgewise Therapeutics Inc stock.